Du Pont Merck taps Dolighan
Du Pont Merck Pharmaceutical has named Richard Dolighan as president of its radiopharmaceuticals division in Billerica, MA. Dolighan most recently served as group vice president and general manager of North America for ICN Pharmaceuticals of Costa Mesa,
Du Pont Merck Pharmaceutical has named Richard Dolighan as president of its radiopharmaceuticals division in Billerica, MA. Dolighan most recently served as group vice president and general manager of North America for ICN Pharmaceuticals of Costa Mesa, CA. Dolighan replaces Kenneth Kasses as head of the Du Pont division.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
